Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2012
03/08/2012CA2810393A1 Method of preparing 3-amino-4-(2-oxo-piperidin-1-yl)-butyric acid derivative for synthesizing medicament
03/08/2012CA2810038A1 Novel compounds and compositions for the inhibition of nampt
03/08/2012CA2810011A1 Adsorption of immunopotentiators to insoluble metal salts
03/08/2012CA2809912A1 Method for the production of 5-fluoro-1h-pyrazolo[3,4-b]pyridine-3-carbonitrile
03/08/2012CA2809911A1 Bicyclic aza heterocycles, and use thereof
03/08/2012CA2809779A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
03/08/2012CA2809553A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors
03/08/2012CA2809492A1 Herbicidally active ketosultams and diketopyridines
03/08/2012CA2809391A1 4-{[(pyridin-3-yl-methyl)aminocarbonyl]amino}benzene-sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/07/2012EP2426191A1 Process for the homogenous hydrogenation of (poly)unsaturated hydrocarbons
03/07/2012EP2426129A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426106A1 Piperidine and Piperazine derivatives for the treatment of tumours
03/07/2012EP2424866A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2424858A1 Cxcr3 receptor antagonists
03/07/2012EP2424856A1 Fused heterocyclic compound and use thereof
03/07/2012EP2424840A1 Cxcr3 receptor antagonists
03/07/2012EP2424532A1 Compounds for inducing cellular apoptosis
03/07/2012EP2424366A1 Pyrido [4, 3-b]indoles and methods of use
03/07/2012EP2424364A1 Pyrido [4,3-b] indoles and methods of use
03/07/2012EP2265120B1 Herbicidal coumpounds
03/07/2012EP1663994B1 Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012CN102369204A 3-deazaneplanocin derivatives
03/07/2012CN102369203A Herbicidal compounds
03/07/2012CN102369202A Azaquinolinone derivatives and uses thereof
03/07/2012CN102369195A Autotaxin inhibitors
03/07/2012CN102369194A Novel pyrazolone-derivatives and their use as PD4 inhibitors
03/07/2012CN102369186A Piperidine and piperazine derivatives as autotaxin inhibitors
03/07/2012CN102367253A Method for preparing Tadalafil crystal form A
03/07/2012CN102093349B Method for performing industrialized production on moxifloxacin hydrochloride
03/07/2012CN101400679B Spiroindolinone derivatives
03/07/2012CN101243084B Pyrrolo[2,3-B]pyridine derivatives as protein kinase inhibitors
03/06/2012US8129404 Compounds and uses thereof
03/06/2012US8129395 4,5-disubstituted-2-aryl pyrimidines
03/06/2012US8129386 Fused azole-pyrimidine derivatives
03/06/2012CA2550868C Spirocyclic cyclohexane derivatives with affinity for the orl1-receptor
03/06/2012CA2543308C Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
03/06/2012CA2498754C Benzimidazolones and their use as cytokine inhibitors
03/06/2012CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
03/01/2012WO2012027702A1 Pyridyl-amine fused azadecalin modulators
03/01/2012WO2012026766A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
03/01/2012WO2012026765A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
03/01/2012WO2012025155A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2011151247A3 Pesticidal compositions
03/01/2012US20120053350 Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
03/01/2012US20120053349 Oxamide derivative
03/01/2012US20120053202 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/01/2012US20120053201 Substituted hydroxamic acids and uses thereof
03/01/2012US20120053188 Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053178 3-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
03/01/2012US20120053175 Mlk inhibitors and methods of use
03/01/2012US20120053171 Nitrogen-Containing Fused Heterocyclic Compounds and Their use as Beta Amyloid Production Inhibitors
03/01/2012US20120053168 Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligands
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053132 Compositions and methods for inhibiting cytochrome p450
03/01/2012US20120052112 Risperidone-containing transdermal preparation and adhesive patch using same
03/01/2012DE102010035744A1 Imidazolonylchinoline Imidazolonylchinoline
03/01/2012CA2806900A1 Pyridyl-amine fused azadecalin modulators
02/2012
02/29/2012EP2423212A1 Process for production of 2-azaadamantane compound from bicyclocarbamate compound
02/29/2012EP2423211A1 Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof
02/29/2012EP2423207A2 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
02/29/2012EP2423192A1 Metal complex having aromatic ligand that contains nitrogen atom
02/29/2012EP2423190A1 Compounds Exhibiting PGD 2 Receptor Antagonism
02/29/2012EP2422779A1 Selective ep4 receptor agonistic substance for treatment of cancer
02/29/2012EP2421870A2 Modulators of 5-ht receptors and methods of use thereof
02/29/2012EP2421866A1 3,3'-spiroindolinone derivatives and their use for cancer
02/29/2012EP2421865A1 Spiroheterocyclic pyrrolidine dione derivatives used as pesticides
02/29/2012EP2421864A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
02/29/2012EP2421863A1 Substituted naphthyridine derivatives and their medical use
02/29/2012EP2421612A1 Heterocyclic compounds as mek inhibitors
02/29/2012EP2421366A1 Heterocyclic fused cinnoline m1 receptor positive allosteric modulators
02/29/2012EP1636208B1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
02/29/2012EP1532153B1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/29/2012CN102365282A 9H-pyrrolo[2,3-B: 5,4-C'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
02/29/2012CN102365281A Indolizine derivative and use thereof for medical purposes
02/29/2012CN102365280A New adenosine receptor ligands and uses thereof
02/29/2012CN102365277A Inhibitors of jun n-terminal kinase
02/29/2012CN101346380B Pyrimidine derivatives for the treatment of abnormal cell growth
02/29/2012CN101060838B Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
02/28/2012US8124770 Fluorescent cellular markers
02/28/2012US8124769 Stereoselective process and crystalline forms of a camptothecin
02/28/2012US8124746 Methods and kits using extended rhodamine dyes
02/28/2012US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives
02/28/2012US8124620 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
02/28/2012US8124619 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
02/28/2012US8124618 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
02/28/2012US8124616 Bicyclic PPAT inhibitors as antibacterial agents
02/28/2012US8124600 5-HT3 receptor modulators, methods of making, and use thereof
02/23/2012WO2012024670A2 Composition and methods for treating glioblastoma
02/23/2012WO2012024564A1 Fluoroalkylation methods and reagents
02/23/2012WO2012024437A1 Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor
02/23/2012WO2012024397A2 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
02/23/2012WO2012024284A1 Lipidated immune response modifier compound compositions, formulations, and methods
02/23/2012WO2012024150A1 Oxadiazole inhibitors of leukotriene production
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 646